Matthew R. Gardner

Emory University — United States

Immunology and Microbiology · Life Sciences

24h-index2.1kcitations65works1.22yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

HIV Research and Treatment(28), Monoclonal and Polyclonal Antibodies Research(15), Virus-based gene therapy research(11), HIV/AIDS drug development and treatment(9), Herpesvirus Infections and Treatments(8)

Publications65 total

The Immunogenicity of AAV-Encoded HIV-1 bNAbs in Rhesus Macaques Is Unaffected by a Short Course of the Immunomodulator CTLA4Ig
AIDS Research and Human Retroviruses·2025Open Access
Determinants of successful AAV-vectored delivery of HIV-1 bNAbs in early life
Nature·2025· 5 citedOpen Access
Geomagnetically Induced Current Field Test on Large Grid-Connected Power Transformers: Analysis, Model Development, and Simulations
2025
Single particle charge detection mass spectrometry enables molecular characterization of lipid nanoparticles and mRNA packaging
Journal of Controlled Release·2025· 2 citedOpen Access
Adeno-associated viral delivery of Env-specific antibodies prevents SIV rebound after discontinuing antiretroviral therapy
Science Immunology·2025· 3 citedOpen Access
6.4 – 00112 Overcoming immune responses directed toward AAV-delivered bNAbs
Journal of Virus Eradication·2024Open Access
PP6.5 – 00086 Regulation of AAV transgene expression using nanoparticledelivered Cre-recombinase
Journal of Virus Eradication·2024Open Access
Abstract 4140609: Engineering and Development of Optimal CRISPR Based Genome Modification Molecules for Safe and Effective LDL-C Lowering
Circulation·2024
Estimating Clock Synchronization Correction Factor from Synchrophasor Phase Angle Drift
2024· 1 cited
Sensitivities of Geomagnetically Induced Currents in Dominion Energy Virginia to the Neighboring Grids and Transformer Blocking Schemes
2023· 2 cited
A strategy for high antibody expression with low anti-drug antibodies using AAV9 vectors
Frontiers in Immunology·2023· 11 citedOpen Access
A lentiviral vector B cell gene therapy platform for the delivery of the anti-HIV-1 eCD4-Ig-knob-in-hole-reversed immunoadhesin
Molecular Therapy — Methods & Clinical Development·2023· 13 citedOpen Access
OP 6.1 It's a mountain not a hill: Progress made in realizing AAV-delivered inhibitors for an HIV cure
Journal of Virus Eradication·2022· 1 citedOpen Access
Seroprevalence of Adeno-Associated Virus Neutralizing Antibodies in Males with Duchenne Muscular Dystrophy
Human Gene Therapy·2022· 20 citedOpen Access
Online Estimation of Geomagnetically Induced Current Effects using Neural Networks
2022 IEEE Power & Energy Society General Meeting (PESGM)·2022
Estimation of the in vivo neutralization potency of eCD4Ig and conditions for AAV-mediated production for SHIV long-term remission
Science Advances·2022· 7 citedOpen Access
High concordance of ELISA and neutralization assays allows for the detection of antibodies to individual AAV serotypes
Molecular Therapy — Methods & Clinical Development·2022· 26 citedOpen Access
Mutations derived from horseshoe bat ACE2 orthologs enhance ACE2-Fc neutralization of SARS-CoV-2
PLoS Pathogens·2021· 137 citedOpen Access
Mutations from bat ACE2 orthologs markedly enhance ACE2-Fc neutralization of SARS-CoV-2
2020· 28 citedOpen Access
Promise and Progress of an HIV-1 Cure by Adeno-Associated Virus Vector Delivery of Anti-HIV-1 Biologics
Frontiers in Cellular and Infection Microbiology·2020· 32 citedOpen Access
page 1 of 4Next →

Frequent Co-authors

Michael Farzan(29), Meredith E. Davis-Gardner(11), Brian D. Quinlan(8), Barnett Alfant(8), Guangping Gao(7), Jesse A. Weber(7), Christoph H. Fellinger(6), Jeffrey D. Lifson(6), Amber S. Zhou(6), Hema R. Kondur(4), Charles C. Bailey(4), Vinita R. Joshi(4), Sebastian Fuchs(4), José M. Martinez-Navío(4), Ronald C. Desrosiers(4), Hyeryun Choe(4), Ina Fetzer(4), Neha R. Prasad(4), Yilu Liu(4), Lisa Kattenhorn(3)